NEW YORK, Sept. 16 (GenomeWeb News) - Illumina signed an agreement to collaborate on a rheumatoid arthritis genotyping study with the North American Rheumatoid Arthritis Consortium, the company said today.
The study involves the analysis of 3,125 samples using Illumina's Linkage IV SNP panel with its BeadArray platform. NARAC researchers will analyze the data in hopes of identifying genes associated with rheumatoid arthritis, Illumina said.
The effort is led by Peter Gregersen, director of the
The company declined to disclose financial details of the deal.